Cellnovo Group S.A. | Mutual Funds
Mutual Funds that own Cellnovo Group S.A.
Government Pension Fund - Global (The)
480,851
3%
480,851
0%
12/31/2017
APO Medical Opportunities
258,570
1.61%
0
0.16%
03/31/2018
225,010
1.4%
0
0.61%
07/31/2018
Sycomore European Growth
161,444
1.01%
95,000
0.28%
12/30/2016
LBPAM Actions Santé
153,100
0.95%
0
0.34%
06/29/2018
Apus Capital Revalue Fonds
146,280
0.91%
146,280
0.27%
09/30/2017
APO Medical Opportunities Institutionell
138,570
0.86%
0
0.23%
06/29/2018
Peacock European Alpha Builder UI
40,000
0.25%
40,000
0.42%
09/30/2017
Etoile Santé Europe
33,786
0.21%
0
0.06%
01/31/2018
20,000
0.13%
13,000
0.15%
06/30/2017
| Address |
13, rue de Londres
Paris Ile-de-France 75009
France
|
|
Employees
|
- |
| Website |
http://www.cellnovo.com |
| Updated |
07/08/2019 |
| Cellnovo Group SA is a medical technology company, which specializes in diabetes. The company develops and markets the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. Its products portfolio includes system, switch, pump therapy, and patient stories. |
